Cart - 6th World Congress on Targeting Phage Therapy 2023 - June 1-2, 2023 - Paris, France

Skip to content

Home
Welcome note
Agenda at a Glance
Faculty
Registration
Abstract Submission
Tracks
Venue
Previous Congresses
Contact
About TID
- Aims

Cart

[woocommerce_cart]

Targeting Phage Therapy News

Cellexus will present their latest research during Targeting Phage Therapy 2023
Targeting Phage Therapy 2023 Venue – IRIS
Targeting Phage Therapy 2023: Many questions remain to be answered!
Bacteriophages & Microbiota: On the Way to a Medical Revolution?
Phage Therapy 2023 Innovations – 10 minutes to Convince

Read more...

Scientific News

AP-PA02 Phage cocktail safely lowers P. aeruginosa load in Cystic Fibrosis trial
Compassionate Use of Phages Against Drug-Resistant Mycobacterial Disease
Tail-Engineered Phage P2 for Antimicrobials Delivery
Potential for Bacteriophages as Anticancer Agents
Managing phage therapy to help save lives
Phage trial to treat CF patients with multi-drug resistant bacterial infections
NIH-supported clinical trial of phage therapy for cystic fibrosis begins
A novel virulent Litunavirus phage against multidrug resistant Pseudomonas aeruginosa
Anti-Biofilm Effect of Bacteriophages & Antibiotics against Uropathogenic E. coli
Bacteriophage Cocktails in the Post-COVID Rehabilitation

Newsletters & Press Release

Phage Therapy 2023 : What is the Next Strategic Step?
Early Bird Registration to Targeting Phage Therapy 2023 – Agenda, Speakers & Abstract Submission
Targeting Phage Therapy 2023: Many questions remain to be answered!
Agenda & Speakers of Targeting Phage Therapy 2023 – Innovation & Abstract Submission
Targeting Phage Therapy 6th World Congress – Speakers and Abstract Submission

Sign up for Newsletter

Sponsors

Media Partners

Upcoming Events

Upcoming Events

Oct 17

October 17 - October 19

Targeting Microbiota 2023 Congress

Scientific News

AP-PA02 Phage cocktail safely lowers P. aeruginosa load in Cystic Fibrosis trial

Compassionate Use of Phages Against Drug-Resistant Mycobacterial Disease

Tail-Engineered Phage P2 for Antimicrobials Delivery

Potential for Bacteriophages as Anticancer Agents

Managing phage therapy to help save lives

Phage trial to treat CF patients with multi-drug resistant bacterial infections

NIH-supported clinical trial of phage therapy for cystic fibrosis begins

A novel virulent Litunavirus phage against multidrug resistant Pseudomonas aeruginosa

Anti-Biofilm Effect of Bacteriophages & Antibiotics against Uropathogenic E. coli

Bacteriophage Cocktails in the Post-COVID Rehabilitation

Zn2+- Releasing Phage Bound to Gold Nanorods for Treating Wound Infections

Engineered Bacteriophages Suppress Antibiotic Resistant P. Aeuruginosa Infection
Read More

Theme: Vogue by Kaira

Copyright © 2023 - Targeting Phage Therapy

Welcome note
Registration
Agenda at a glance
Abstract Submission
Tracks
Faculty
Previous Congresses

Scientific News
Legal Mentions & Privacy Policy
General Conditions of Sales
Contact